LEADER 01741nam  2200433   450 
001 9910715007403321
005 20201202085421.0
035   $a(CKB)5470000002507934
035   $a(OCoLC)1225073215
035   $a(EXLCZ)995470000002507934
100   $a20201202d2020      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aDefense Production Act: opportunities exist to increase transparency and identify future actions to mitigate medical supply chain issues $ereport to congressional committees
210  1$a[Washington, D.C.] :$cUnited States Government Accountability Office,$d2020.
215   $a1 online resource (ii, 35 pages) $ccolor illustrations
300   $a"November 2020."
300   $a"GAO-21-108."
320   $aIncludes bibliographical references.
517   $aDefense Production Act
606   $aEmergency management$xFinance$xLaw and legislation$zUnited States
606   $aCOVID-19 (Disease)$zUnited States
606   $aTransparency in government$xLaw and legislation$zUnited States
606   $aMedical supplies$zUnited States
606   $aPublic health administration$zUnited States
615  0$aEmergency management$xFinance$xLaw and legislation
615  0$aCOVID-19 (Disease)
615  0$aTransparency in government$xLaw and legislation
615  0$aMedical supplies
615  0$aPublic health administration
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910715007403321
996   $aDefense Production Act: opportunities exist to increase transparency and identify future actions to mitigate medical supply chain issues$93529701
997   $aUNINA